Calamos Wealth Management LLC Has $13.69 Million Stock Holdings in Zoetis Inc. (NYSE:ZTS)

Calamos Wealth Management LLC boosted its stake in Zoetis Inc. (NYSE:ZTS) by 21.0% during the fourth quarter, HoldingsChannel reports. The firm owned 84,030 shares of the company’s stock after buying an additional 14,568 shares during the period. Calamos Wealth Management LLC’s holdings in Zoetis were worth $13,691,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Mizuho Securities USA LLC increased its stake in Zoetis by 13,726.9% during the 3rd quarter. Mizuho Securities USA LLC now owns 4,865,000 shares of the company’s stock valued at $950,524,000 after purchasing an additional 4,829,815 shares in the last quarter. International Assets Investment Management LLC boosted its stake in shares of Zoetis by 41,235.7% during the third quarter. International Assets Investment Management LLC now owns 939,974 shares of the company’s stock worth $183,652,000 after buying an additional 937,700 shares during the period. Assenagon Asset Management S.A. boosted its stake in shares of Zoetis by 296.9% during the 4th quarter. Assenagon Asset Management S.A. now owns 889,444 shares of the company’s stock worth $144,917,000 after acquiring an additional 665,331 shares in the last quarter. Nordea Investment Management AB boosted its holdings in shares of Zoetis by 38.3% during the fourth quarter. Nordea Investment Management AB now owns 2,065,514 shares of the company’s stock worth $336,266,000 after purchasing an additional 572,511 shares during the last quarter. Finally, Holocene Advisors LP acquired a new position in shares of Zoetis during the third quarter worth about $110,809,000. 92.80% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

ZTS has been the subject of several recent research reports. Leerink Partners started coverage on shares of Zoetis in a research note on Monday, December 2nd. They set an “outperform” rating and a $215.00 target price for the company. Morgan Stanley reduced their target price on Zoetis from $248.00 to $243.00 and set an “overweight” rating on the stock in a report on Wednesday, January 29th. UBS Group assumed coverage on shares of Zoetis in a research note on Monday, December 9th. They issued a “neutral” rating and a $196.00 price target on the stock. Stifel Nicolaus dropped their price objective on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating for the company in a report on Tuesday, January 7th. Finally, Leerink Partnrs upgraded Zoetis to a “strong-buy” rating in a research note on Monday, December 2nd. One research analyst has rated the stock with a hold rating, ten have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Buy” and an average target price of $215.00.

Zoetis Stock Performance

NYSE ZTS opened at $171.93 on Tuesday. Zoetis Inc. has a twelve month low of $144.80 and a twelve month high of $200.53. The stock has a fifty day simple moving average of $169.62 and a 200 day simple moving average of $179.44. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26. The company has a market capitalization of $77.57 billion, a price-to-earnings ratio of 32.32, a PEG ratio of 2.72 and a beta of 0.90.

Zoetis (NYSE:ZTS) last issued its quarterly earnings data on Monday, November 4th. The company reported $1.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.46 by $0.12. The firm had revenue of $2.40 billion during the quarter, compared to the consensus estimate of $2.29 billion. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The company’s revenue for the quarter was up 11.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.36 EPS. Sell-side analysts expect that Zoetis Inc. will post 5.9 EPS for the current year.

Zoetis Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 4th. Stockholders of record on Tuesday, January 21st will be paid a $0.50 dividend. This is a boost from Zoetis’s previous quarterly dividend of $0.43. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 1.16%. Zoetis’s dividend payout ratio is 37.59%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.